Year: 2021

TORONTO, Dec. 17, 2021 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (the “Company”) announced today that it has implemented an automatic repurchase plan with effect from Monday, December 20, 2021 with its designated broker in order to facilitate purchases of its common shares under its previously announced normal course issuer bid (“NCIB”) at times when the Company ordinarily would not be active in the market due to regulatory restrictions or self-imposed blackout periods. Purchases made pursuant to the automatic repurchase plan, if any, will be made by the Company’s designated broker based upon the parameters prescribed by the Toronto Stock Exchange (“TSX”), applicable Canadian securities laws and the terms of the written agreement between the Company and its designated broker. The automatic repurchase plan constitutes...

SHERBROOKE, Québec, Dec. 17, 2021 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX: KPT) and Kruger Products L.P. (“KPLP”) today announced KPLP’s plan to add to the capacity of its Sherbrooke expansion project by constructing a double width Light Dry Crepe (LDC) tissue machine with a capacity of at least 60,000 MT instead of the previously announced 30,000 MT LDC tissue machine. This additional capacity will allow us to accelerate the growth of our business and continue to provide our customers across North America with high quality tissue products like Cashmere®, SpongeTowels®, Scotties® and Purex® in Canada and White Cloud® in the U.S., said Dino Bianco, CEO with KPLP. With this enhancement, the total estimated cost of the Sherbrooke expansion project, which also includes the previously announced addition of a bathroom tissue converting...

Final step of the financial restructuring to be completed shortlyReference is made to earlier information provided regarding the financial restructuring process of Prosafe SE and Prosafe Rigs Pte. Ltd. (“PRPL”). Prosafe SE is pleased to announce that the conditions for the Schemes in Singapore for becoming effectively implemented have been met, following which the Transaction Effective Date in accordance with the Schemes has occurred. Following occurrence of the Transaction Effective Date, the conversion of USD 996 million of debt (the “Step 1 Conversion”) in return for 7 894 088 600 shares in Prosafe SE (the “Tranche 1 Shares”) has been implemented. After the Step 1 conversion, the aggregate amount of 7 894 088 600 shares has today been issued at a conversion rate of EUR 0.1116. The total number of...

MONTREAL, Dec. 17, 2021 (GLOBE NEWSWIRE) — Vision Marine Technologies, Inc. (NASDAQ: VMAR) (“Vision Marine” or the “Company”), the global leader in the electric transition of the recreational boating industry serving both OEMs and consumers, is pleased to announce that Xavier Montagne, presently Vision Marine’s Chief Technology Officer, has been appointed to the additional role of Chief Operating Officer. Xavier Montagne has been a visionary regarding the design and building of our first generation fully electric propulsion system, the groundbreaking E-Motion 180e. Mr. Montagne has been responsible for direct involvement with the engineers from McLaren Engineering, a division of Linamar Corporation (TSX: LNR), and has been instrumental in moving forward Vision Marine’s capability to scale production for sale to global OEMs. Prior...

PHILADELPHIA, Dec. 17, 2021 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective as of market open on Monday, December 20, 2021. The NBI is designed to track the performance of a set of securities listed on the NASDAQ Stock Market® (NASDAQ®), made up of NASDAQ-listed companies classified as Biotechnology & Pharmaceuticals by the Industry Classification Benchmark (ICB), and is widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. To be selected for addition to the NBI, a company must have a minimum market capitalization...

BOSTON, Dec. 17, 2021 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that the company has been added to the NASDAQ Biotech Index (Nasdaq: NBI), effective prior to market open on Monday, December 20, 2021. “We are pleased to join the NASDAQ Biotechnology Index as it heightens and expands our profile within the investment community,” said Jean Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals. “Inclusion in the index broadens awareness of Atea and its mission to develop safe and effective oral antiviral treatments that address unmet medical needs of patients with life-threatening viral diseases, including COVID-19.” The NASDAQ Biotechnology Index is designed to track the performance of a set of securities...

Innofactor Plc Inside Information December 17, 2021, at 13:45 Finnish time Innofactor and a large Finnish globally operating manufacturing industry company have signed a contract to continue the work on digitalization of the company’s quotation process. Innofactor will continue the work started in 2020 to design and implement, using agile methods, a cloud-based solution for managing the quotation process and handling and storing related information and documents. The solution is implemented using Microsoft Azure PaaS cloud services. The total value (excluding VAT) of the contract is approximately EUR 1,200,000 and the services will be delivered during the year 2022. Espoo, December 17, 2021 INNOFACTOR PLC Sami Ensio, CEO Additional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.com Distribution:NASDAQ...